Sucampo and Takeda Announce Update on Liquid Formulation Program for

Sucampo and Takeda Announce Update on Liquid Formulation Program for
AMITIZA 24 mcg twice daily is also approved to treat constipation caused by opioids, a type of prescription pain medicine, in adults with chronic, noncancer pain. … The most common side effects of taking AMITIZA (24 mcg) twice daily are nausea …
Read more on Wall Street Journal

More Methadone Pain Killer Side Effects Information…